Prevalence of markers of hepatitis B infection in the adult population of the district of Coimbra.
Autor(a) principal: | |
---|---|
Data de Publicação: | 2000 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1790 |
Resumo: | To assess the prevalence of hepatitis B markers in the adult population of the Coimbra district, in the central region of Portugal.The study included 657 subjects chosen aleatorily from 4 characteristic councils of the Coimbra district. They were questioned regarding risk factors and blood samples were taken for HBsAg, anti-HBs and anti-HBc testing. Anti-HCV was previously determined and it was positive in 0.45% of the cases.HBsAg was found in 0.91%. Anti-HBs and anti-HBc were both positive in 6.08%, anti-HBc without anti-HBs was found in 1.82% and anti-HBs without anti-HBc was found in 1.67% (11 cases, 8 vaccinated). The general prevalence of hepatitis B markers was 9.3%. Higher prevalences were found in the subjects over 50 years of age, 13.5% (p < 0.05), and in the urban area, 13.2% (p < 0.05).1. The HBsAg prevalence in our region is 0.9%; 2. The general prevalence of hepatitis B markers is 9.3%; 3. HBsAg prevalence is higher than anti-HCV prevalence calculated in the same sample; 4. The prevalence of hepatitis B markers in our region is lower than in other Southern European countries. |
id |
RCAP_d976a4083fe0686fca898ae3d0058c84 |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/1790 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Prevalence of markers of hepatitis B infection in the adult population of the district of Coimbra.Prevalência dos marcadores de infecção pelo vírus da hepatite B na população adulta do distrito de Coimbra.To assess the prevalence of hepatitis B markers in the adult population of the Coimbra district, in the central region of Portugal.The study included 657 subjects chosen aleatorily from 4 characteristic councils of the Coimbra district. They were questioned regarding risk factors and blood samples were taken for HBsAg, anti-HBs and anti-HBc testing. Anti-HCV was previously determined and it was positive in 0.45% of the cases.HBsAg was found in 0.91%. Anti-HBs and anti-HBc were both positive in 6.08%, anti-HBc without anti-HBs was found in 1.82% and anti-HBs without anti-HBc was found in 1.67% (11 cases, 8 vaccinated). The general prevalence of hepatitis B markers was 9.3%. Higher prevalences were found in the subjects over 50 years of age, 13.5% (p < 0.05), and in the urban area, 13.2% (p < 0.05).1. The HBsAg prevalence in our region is 0.9%; 2. The general prevalence of hepatitis B markers is 9.3%; 3. HBsAg prevalence is higher than anti-HCV prevalence calculated in the same sample; 4. The prevalence of hepatitis B markers in our region is lower than in other Southern European countries.To assess the prevalence of hepatitis B markers in the adult population of the Coimbra district, in the central region of Portugal.The study included 657 subjects chosen aleatorily from 4 characteristic councils of the Coimbra district. They were questioned regarding risk factors and blood samples were taken for HBsAg, anti-HBs and anti-HBc testing. Anti-HCV was previously determined and it was positive in 0.45% of the cases.HBsAg was found in 0.91%. Anti-HBs and anti-HBc were both positive in 6.08%, anti-HBc without anti-HBs was found in 1.82% and anti-HBs without anti-HBc was found in 1.67% (11 cases, 8 vaccinated). The general prevalence of hepatitis B markers was 9.3%. Higher prevalences were found in the subjects over 50 years of age, 13.5% (p < 0.05), and in the urban area, 13.2% (p < 0.05).1. The HBsAg prevalence in our region is 0.9%; 2. The general prevalence of hepatitis B markers is 9.3%; 3. HBsAg prevalence is higher than anti-HCV prevalence calculated in the same sample; 4. The prevalence of hepatitis B markers in our region is lower than in other Southern European countries.Ordem dos Médicos2000-08-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1790oai:ojs.www.actamedicaportuguesa.com:article/1790Acta Médica Portuguesa; Vol. 13 No. 4 (2000): Julho-Agosto; 167-71Acta Médica Portuguesa; Vol. 13 N.º 4 (2000): Julho-Agosto; 167-711646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1790https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1790/1367Santos, ACarvalho, ATomaz, JRodrigues, VCoxinho, LBento, DSá, RPorto, Ainfo:eu-repo/semantics/openAccess2022-12-20T10:59:04Zoai:ojs.www.actamedicaportuguesa.com:article/1790Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:17:23.834671Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Prevalence of markers of hepatitis B infection in the adult population of the district of Coimbra. Prevalência dos marcadores de infecção pelo vírus da hepatite B na população adulta do distrito de Coimbra. |
title |
Prevalence of markers of hepatitis B infection in the adult population of the district of Coimbra. |
spellingShingle |
Prevalence of markers of hepatitis B infection in the adult population of the district of Coimbra. Santos, A |
title_short |
Prevalence of markers of hepatitis B infection in the adult population of the district of Coimbra. |
title_full |
Prevalence of markers of hepatitis B infection in the adult population of the district of Coimbra. |
title_fullStr |
Prevalence of markers of hepatitis B infection in the adult population of the district of Coimbra. |
title_full_unstemmed |
Prevalence of markers of hepatitis B infection in the adult population of the district of Coimbra. |
title_sort |
Prevalence of markers of hepatitis B infection in the adult population of the district of Coimbra. |
author |
Santos, A |
author_facet |
Santos, A Carvalho, A Tomaz, J Rodrigues, V Coxinho, L Bento, D Sá, R Porto, A |
author_role |
author |
author2 |
Carvalho, A Tomaz, J Rodrigues, V Coxinho, L Bento, D Sá, R Porto, A |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Santos, A Carvalho, A Tomaz, J Rodrigues, V Coxinho, L Bento, D Sá, R Porto, A |
description |
To assess the prevalence of hepatitis B markers in the adult population of the Coimbra district, in the central region of Portugal.The study included 657 subjects chosen aleatorily from 4 characteristic councils of the Coimbra district. They were questioned regarding risk factors and blood samples were taken for HBsAg, anti-HBs and anti-HBc testing. Anti-HCV was previously determined and it was positive in 0.45% of the cases.HBsAg was found in 0.91%. Anti-HBs and anti-HBc were both positive in 6.08%, anti-HBc without anti-HBs was found in 1.82% and anti-HBs without anti-HBc was found in 1.67% (11 cases, 8 vaccinated). The general prevalence of hepatitis B markers was 9.3%. Higher prevalences were found in the subjects over 50 years of age, 13.5% (p < 0.05), and in the urban area, 13.2% (p < 0.05).1. The HBsAg prevalence in our region is 0.9%; 2. The general prevalence of hepatitis B markers is 9.3%; 3. HBsAg prevalence is higher than anti-HCV prevalence calculated in the same sample; 4. The prevalence of hepatitis B markers in our region is lower than in other Southern European countries. |
publishDate |
2000 |
dc.date.none.fl_str_mv |
2000-08-30 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1790 oai:ojs.www.actamedicaportuguesa.com:article/1790 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1790 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/1790 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1790 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1790/1367 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 13 No. 4 (2000): Julho-Agosto; 167-71 Acta Médica Portuguesa; Vol. 13 N.º 4 (2000): Julho-Agosto; 167-71 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130627090415616 |